UBS Confirms Dividend and New Board as $26 Billion Capital Clash Reaches Climax

UBS shareholders approve dividend and elect new board members, but the bank faces a $22B+ capital threat from Swiss regulations as it integrates Credit Suisse.

Shareholders of UBS have formally approved a $1.10 per share dividend, with the payment set to land in investor accounts on April 23. To qualify, investors must hold the stock by this coming Monday, after which the shares will trade ex-dividend on Tuesday. The bank’s stock recently traded around 34 Swiss francs.

The annual meeting also saw a significant refresh of the bank’s supervisory board. Luca Maestri, the long-serving Chief Financial Officer of Apple, and Agustín Carstens, the former General Manager of the Bank for International Settlements, were newly elected. The market views these appointments as a strategic signal, bringing crucial expertise in capital allocation and global monetary policy to a bank deeply engaged in its own digital transformation and the massive integration of Credit Suisse.

Beneath this surface of shareholder approval and new leadership, however, a multibillion-dollar regulatory storm is brewing. UBS Chairman Colm Kelleher used the meeting to launch sharp criticism at the Swiss Federal Council. The core dispute centers on proposed rules that would require foreign subsidiaries to be fully backed with high-quality CET1 capital. Internal calculations suggest this could create an additional capital requirement of up to $26 billion, a figure Kelleher warns would severely damage the bank’s international competitiveness.

The immediate regulatory fate of UBS will be decided in a crucial few days. On April 22, the Federal Council is expected to rule on how deferred tax assets are treated under CET1 rules. Analysts at Bank of America see a good chance for relief, with their base case scenario projecting the capital hit from intangible asset rules could fall to around $6.2 billion from a current estimate of $10.8 billion. While a positive outcome would provide some respite, the overall regulatory package remains burdensome. UBS itself estimates the combined capital impact of all proposed reforms at approximately $22 billion above its end-2024 level.

A potentially more consequential parliamentary debate on the treatment of foreign subsidiaries is scheduled for May 4. A lenient ruling from the Federal Council on April 22 could set a favorable tone for that legislative process. The stock, which gained about 12% over the past month to trade recently at 36.45 euros, appears to have priced in some of these expectations, though it remains roughly 11% below its January peak.

Investors will soon shift their focus from regulatory wrangling to operational performance. UBS is scheduled to report its first-quarter 2026 results on April 29. All eyes will be on the bank’s return on equity, a key metric where management is targeting around 15% for the full year. The figures will offer the first concrete evidence of whether the Credit Suisse integration is delivering the promised synergies and if the bank is on track to meet elevated earnings per share expectations of $3.22 for 2026. This follows a strong 2025, where UBS posted a net profit of $7.8 billion, a 53% increase from the prior year.

The coming week is therefore pivotal, framing UBS’s journey between a confirmed dividend, a strengthened board, a looming capital reckoning, and the need to prove its profit engine is firing on all cylinders.